AMICUS THERAPEUTICS, INC. (FOLD)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch FOLD
See up to 3 months of FOLD. The 7-day demo opens the 1M and 3M ranges and puts FOLD on your watchlist.
Start 7-day demoLatest FOLD insider trades
About AMICUS THERAPEUTICS, INC. (FOLD)
AMICUS THERAPEUTICS, INC. files with the SEC under CIK 0001178879 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
FOLD Form 4 activity by transaction type, last 90 days
No Form 4 activity for FOLD in the last 90 days.
FOLD insider transactions (Form 4)
14245 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Craig A. Wheeler | Derivative | Common Stock | 84,631 footnote F1 | $14.50 | $1.23M | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 30,000 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 16,236 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 19,473 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Craig A. Wheeler | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Margaret G. McGlynn | Derivative | Common Stock | 94,631 footnote F1 | $14.50 | $1.37M | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 20,000 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 16,236 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 19,473 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Margaret G. McGlynn | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Burke W. Whitman | Derivative | Common Stock | 118,598 footnote F1 | $14.50 | $1.72M | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 25,964 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Burke W. Whitman | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Common Stock | 142,564 footnote F1 | $14.50 | $2.07M | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 20,000 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 16,236 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 19,473 | - footnote F2 | - | |
| Glenn Sblendorio | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Eiry Roberts | Derivative | Common Stock | 76,275 footnote F1 | $14.50 | $1.11M | |
| Eiry Roberts | Derivative | Stock Options (right to buy) | 40,625 | - footnote F2 | - | |
| Eiry Roberts | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Eiry Roberts | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Eiry Roberts | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Eiry Roberts | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Lynn Dorsey Bleil | Derivative | Common Stock | 113,941 footnote F1 | $14.50 | $1.65M | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 14,605 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 19,473 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Lynn Dorsey Bleil | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Michael Aaron Kelly | Derivative | Common Stock | 72,468 footnote F1 | $14.50 | $1.05M | |
| Michael Aaron Kelly | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Michael Aaron Kelly | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Michael Aaron Kelly | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Michael Aaron Kelly | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Michael Aaron Kelly | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
 Michael Raab | Derivative | Common Stock | 115,857 footnote F1 | $14.50 | $1.68M | |
| Michael Raab | Derivative | Stock Options (right to buy) | 20,000 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 16,236 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 19,473 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 18,574 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 36,111 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 45,423 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 30,474 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 42,467 | - footnote F2 | - | |
| Michael Raab | Derivative | Stock Options (right to buy) | 74,872 | - footnote F2 | - | |
| ||||||
| Samantha Prout - Officer | Derivative | Common Stock | 125,951 footnote F1 | $14.50 | $1.83M | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 2,526 | - footnote F2 | - | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 3,176 | - footnote F2 | - | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 37,810 | - footnote F2 | - | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 55,203 | - footnote F2 | - | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 43,592 | - footnote F2 | - | |
| Samantha Prout - Officer | Derivative | Stock Options (right to buy) | 62,715 | - footnote F2 | - | |
| ||||||
| Jeff Castelli - Officer | Derivative | Common Stock | 427,089 footnote F1 | $14.50 | $6.19M | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 82,644 | - footnote F2 | - | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 107,575 | - footnote F2 | - | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 108,266 | - footnote F2 | - | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 125,462 | - footnote F2 | - | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 99,073 | - footnote F2 | - | |
| Jeff Castelli - Officer | Derivative | Stock Options (right to buy) | 150,517 | - footnote F2 | - | |
| ||||||
| David Michael Clark - Officer | Derivative | Common Stock | 221,811 footnote F1 | $14.50 | $3.22M | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 84,842 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 77,134 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 91,439 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 108,266 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 105,388 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 83,221 | - footnote F2 | - | |
| David Michael Clark - Officer | Derivative | Stock Options (right to buy) | 125,430 | - footnote F2 | - | |
| ||||||
| Ellen Rosenberg - Officer | Derivative | Common Stock | 463,898 footnote F1 | $14.50 | $6.73M | |
| Ellen Rosenberg - Officer | Derivative | Common Stock | 15,000 footnote F2 | $14.50 | $218K | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 93,663 | - footnote F3 | - | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 107,575 | - footnote F3 | - | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 134,044 | - footnote F3 | - | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 138,008 | - footnote F3 | - | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 108,980 | - footnote F3 | - | |
| Ellen Rosenberg - Officer | Derivative | Stock Options (right to buy) | 203,825 | - footnote F3 | - | |
| ||||||
 Simon N.R. Harford - Officer | Derivative | Common Stock | 143,595 footnote F1 | $14.50 | $2.08M | |
| Simon N.R. Harford - Officer | Derivative | Stock Options (right to buy) | 189,043 | - footnote F2 | - | |
| Simon N.R. Harford - Officer | Derivative | Stock Options (right to buy) | 99,073 | - footnote F2 | - | |
| Simon N.R. Harford - Officer | Derivative | Stock Options (right to buy) | 150,517 | - footnote F2 | - | |
| ||||||
| Bradley L. Campbell - Officer | Derivative | Common Stock | 1,008,680 footnote F1 | $14.50 | $14.63M | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 103,578 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 151,515 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 188,257 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 283,555 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 187,970 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 301,109 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 265,517 | - footnote F2 | - | |
| Bradley L. Campbell - Officer | Derivative | Stock Options (right to buy) | 482,908 | - footnote F2 | - | |
| ||||||
| Bradley L. Campbell - Officer | Open-market sale | Common Stock | 22,500 | $14.35 footnote F1 | $323K | |
| ||||||
| Bradley L. Campbell - Officer | Option exercise | Common Stock | 75,000 | $6.10 | $458K | |
| Bradley L. Campbell - Officer | Open-market sale | Common Stock | 75,000 | $14.31 footnote F1 | $1.07M | |
| Bradley L. Campbell - Officer | Option exercise | Stock Options (right to buy) | 75,000 | $0.00 | - | |
| ||||||
| Ellen Rosenberg - Officer | Tax withholding / forfeiture | Common Stock | 13,426 | $14.27 | $192K | |
| Ellen Rosenberg - Officer | Tax withholding / forfeiture | Common Stock | 29,683 | $14.27 | $424K | |
| Jeff Castelli - Officer | Tax withholding / forfeiture | Common Stock | 6,905 | $14.27 | $99K | |
| Jeff Castelli - Officer | Tax withholding / forfeiture | Common Stock | 23,102 | $14.27 | $330K | |
| Samantha Prout - Officer | Tax withholding / forfeiture | Common Stock | 3,443 | $14.27 | $49K | |
| Samantha Prout - Officer | Tax withholding / forfeiture | Common Stock | 12,240 | $14.27 | $175K | |
| David Michael Clark - Officer | Tax withholding / forfeiture | Common Stock | 5,381 | $14.27 | $77K | |
| David Michael Clark - Officer | Tax withholding / forfeiture | Common Stock | 18,498 | $14.27 | $264K | |
| Bradley L. Campbell - Officer | Tax withholding / forfeiture | Common Stock | 108,602 | $14.25 | $1.55M | |
| Simon N.R. Harford - Officer | Tax withholding / forfeiture | Common Stock | 71,303 | $14.25 | $1.02M | |
| David Michael Clark - Officer | Open-market sale | Common Stock | 25,642 | $14.17 | $363K | |
| Bradley L. Campbell - Officer | Option exercise | Common Stock | 70,426 | $9.03 | $636K | |
| Bradley L. Campbell - Officer | Open-market sale | Common Stock | 77,926 | $10.86 footnote F1 | $846K | |
| Bradley L. Campbell - Officer | Option exercise | Stock Options (right to buy) | 70,426 | $0.00 | - | |
| ||||||
| David Michael Clark - Officer | Open-market sale | Common Stock | 25,643 | $11.00 | $282K | |
| Bradley L. Campbell - Officer | Option exercise | Common Stock | 14,587 | $9.03 | $132K | |
| Bradley L. Campbell - Officer | Open-market sale | Common Stock | 14,587 | $10.01 footnote F1 | $146K | |
| Bradley L. Campbell - Officer | Option exercise | Stock Options (right to buy) | 14,587 | $0.00 | - | |
| ||||||
| Samantha Prout - Officer | Grant or award | Common Stock | 32,193 | $0.00 footnote F1 | - | |
| ||||||
| Jeff Castelli - Officer | Option exercise | Common Stock | 50,000 | $9.03 | $451K | |
| Jeff Castelli - Officer | Open-market sale | Common Stock | 76,158 | $10.16 footnote F1 | $774K | |
| Jeff Castelli - Officer | Option exercise | Stock Options (right to buy) | 50,000 | $0.00 | - | |
| ||||||
| David Michael Clark - Officer | Open-market sale | Common Stock | 25,643 | $10.10 footnote F1 | $259K | |
| ||||||
| Bradley L. Campbell - Officer | Option exercise | Common Stock | 14,587 | $9.03 | $132K | |
| Bradley L. Campbell - Officer | Open-market sale | Common Stock | 14,587 | $10.04 footnote F1 | $147K | |
| Bradley L. Campbell - Officer | Option exercise | Stock Options (right to buy) | 14,587 | $0.00 | - | |
| ||||||
Item 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Item 8.01
Item 5.07, 9.01
Item 2.02, 9.01
FOLD insider trading FAQ
What is the latest insider trade for FOLD?
AMICUS THERAPEUTICS, INC. (FOLD) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-04-27. The full record for FOLD runs to 45 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying FOLD stock?
No insider purchases of FOLD were filed in the last 90 days.
How many insiders are selling FOLD stock?
No insider sales of FOLD were filed in the last 90 days. 17 sales are on record for this company.
Where can I see FOLD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects FOLD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Craig A. Wheeler view on EDGAR
- - Margaret G. McGlynn view on EDGAR
- - Burke W. Whitman view on EDGAR
- - Glenn Sblendorio view on EDGAR
- - Eiry Roberts view on EDGAR
- - Lynn Dorsey Bleil view on EDGAR
- - Michael Aaron Kelly view on EDGAR
- - Michael Raab view on EDGAR
- - Samantha Prout view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where FOLD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow FOLD with a 7-day demo
- FOLD on your watchlist
- Every FOLD Form 4 filing on record
- Up to 3 months of FOLD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
